TTF-1 Negativity Predicts Poor Outcomes in Advanced Non-Squamous NSCLC Also in the Immunotherapy Era: A Multicenter Cohort Study and Meta-Analysis.

Cancers (Basel) · 2025 · PMC12248803 · PMID 40647486

Europe PMC DOI

hedged sentence

0.2300

closest p · 4.6× alpha

0.2300

boldest claim

The sentences

did not reach statistical significancep = 0.23not close (p > 0.1)

Again, the TTF-1−/PD-L1 high subgroup did not reach statistical significance (HR 0.62, 95% CI 0.28–1.37, p = 0.23).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.